Hepatocellular carcinoma (HCC) remains a global health burden, and is mostly diagnosed
at late and advanced stages. Currently, limited and insensitive diagnostic modalities …

Viral hepatitis is a major worldwide public health issue, affecting hundreds of millions of
people and causing substantial morbidity and mortality. The majority of the worldwide …

Background Hepatocellular carcinoma (HCC) occurs mostly in people with chronic liver
disease and ranks sixth in terms of global instances of cancer, and fourth in terms of cancer …

Identifying and translating hepatocellular carcinoma (HCC) biomarkers from bench to
bedside using mass spectrometry-based metabolomics and lipidomics is hampered by …

Simple Summary Hepatocellular carcinoma is diagnosed using ultrasound and blood-
biomarker AFP, which can miss up to 40% of diagnoses, delaying the treatment of these …

Background and study aim: Hepatocellular‏‏ Carcinoma (HCC) is regarded as one of the most‎
widespread leading causes of mortality annually. The most‎ frequent risk factors for HCC are …

Background: Hepatocellular carcinoma (HCC) is a highly malignant cancer which lack of
effective diagnosis and prognosis biomarkers, therefore surging studies focused on the …

Liver cirrhosis (LC) represents a significant hepatic disorder that persistently commands the
attention of the scientific community, especially concerning its pathogenesis and therapeutic …

摘要目的探讨病毒性肝炎肝硬化患者早期肝细胞癌代谢变化及其与衰老和酶活性的关系.
方法以140 例患者为研究对象, 根据诊断结果分为肝硬化组(LC 组), 肝硬化肝细胞癌组(CLH 组) …

Globally, hepatocellular carcinoma (HCC) is one of the most commonly encountered
cancers. Because the current early diagnostic tests for HCC are not very sensitive, most …